Effect of the Mycotoxin Deoxynivalenol in Combinational Therapy with TRAIL on Prostate Cancer Cells

The authors demonstrated that three out of four tested prostate cancer cell lines pretreated with mycotoxin deoxynivalenol increased tumor necrosis factor-related apoptosis-induced ligand (TRAIL)-induced apoptosis detected with flow cytometry.